Vetoquinol SA (LON:0O1O)
79.70
-0.40 (-0.50%)
At close: Sep 17, 2025
Vetoquinol Revenue
Vetoquinol had revenue of 257.63M EUR in the half year ending June 30, 2025, with 0.54% growth. This brings the company's revenue in the last twelve months to 532.39M, down -0.95% year-over-year. In the year 2024, Vetoquinol had annual revenue of 539.20M with 1.88% growth.
Revenue (ttm)
532.39M EUR
Revenue Growth
-0.95%
P/S Ratio
1.76
Revenue / Employee
212.87K EUR
Employees
2,501
Market Cap
804.13M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 539.20M | 9.93M | 1.88% |
Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |